New Exchange Agreement, Technical Updates, Upcoming Event Participation, and Investor Day - Research Reports on ExxonMobil, Monsanto, Schlumberger, Chevron and TransCanada

NEW YORK, September 23, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Exxon Mobil Corporation (NYSE: XOM), Monsanto Company (NYSE: MON), Schlumberger Limited (NYSE: SLB), Chevron Corporation (NYSE: CVX) and TransCanada Corporation (NYSE: TRP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6675-100free.

--
Exxon Mobil Corporation Research Reports
On September 18, 2014, Exxon Mobil Corporation (ExxonMobil) announced that the Company has entered into a non-monetary exchange agreement with LINN Energy, LLC (LINN) to add 17,800 net acres in the Permian Basin to its U.S. oil and natural gas portfolio managed by its subsidiary XTO Energy Inc. (XTO). The Company informed that in exchange it will give c. 500 net acres in South Belridge Field, near Bakersfield, California to LINN. Under the terms of the agreement, the Company will receive 17,000 net acres in the Midland Basin core area in west Texas that is most prospective for horizontal Wolfcamp and Spraberry development, plus 800 net acres in the New Mexico Delaware Basin. LINN Energy will acquire ExxonMobil's interests in the South Belridge Field, which currently produces approximately 3,400 barrels of oil per day. "We continue to expand our leasehold position in a prolific area that is poised for profitable volumes growth from multiple horizons in the Wolfcamp and Spraberry formations," said Randy Cleveland, President of XTO. The full research reports on ExxonMobil are available to download free of charge at:

http://www.analystsreview.com/Sep-23-2014/XOM/report.pdf

--
Monsanto Company Research Reports
On September 18, 2014, shares in Monsanto Company (Monsanto) gained 1.58% to close Thursday's session at $115.49, reversing the loss made in previous trading session. On the same day, TheStreet.com reported that Stifel has upgraded the Company's stock to 'buy' from 'hold' with a price target of $135. Monsanto's stock opened the session at $114.92 and oscillated in the range of $114.28 - $115.52. A total of 6.02 million shares changed hands during the session, higher than its 30-day average volume of 3.60 million shares. Over the past six months, the stock has strengthened 2.32%. The full research reports on Monsanto are available to download free of charge at:

http://www.analystsreview.com/Sep-23-2014/MON/report.pdf

--
Schlumberger Limited Research Reports
Schlumberger Limited (Schlumberger) posted on the Events Calendar section of its official website that the Company will participate in the upcoming Cowen Annual Oilfield Tour on September 23, 2014 through Thursday, September 25, 2014, to be held in Houston. The full research reports on Schlumberger are available to download free of charge at:

http://www.analystsreview.com/Sep-23-2014/SLB/report.pdf

--
Chevron Corporation Research Reports
On September 18, 2014, Chevron Corporation's (Chevron) stock ended the trading session at $124.14, down 0.47% from its previous day's close of $124.72. During the session, the stock fluctuated between intra-day low of $123.85 and intra-day high of $125.04, with 4.69 million shares changing hands. Thursday's close of Chevron's stock was 8.11% below its 52-week high of $135.10. The stock has surged 7.76% in the last six months, as compared to S&P 500 that gained 8.09% over the same period of time. Moreover, the stock closed above its 200-day moving average of $121.15. The full research reports on Chevron are available to download free of charge at:

http://www.analystsreview.com/Sep-23-2014/CVX/report.pdf

--
TransCanada Corporation Research Reports
According to the Events and Presentations section on TransCanada Corporation's (TransCanada) official site, the Company will hold its Investor Day 2014 on November 18, 2014 through November 19, 2014. The full research reports on TransCanada are available to download free of charge at:

http://www.analystsreview.com/Sep-23-2014/TRP/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.